The Single-Dose Janssen Ad26.COV2.S COVID-19 Vaccine Elicited Robust and Persistent Anti-Spike IgG Antibody Responses in A 12-Month Ugandan Cohort (2024)
Attributed to:
Immunomodulation and Vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.20944/preprints202401.0089.v1
Publication URI: http://dx.doi.org/10.20944/preprints202401.0089.v1
Type: Preprint